| [1] |
KANG Li-ying;GAO Li-ming;CAO Jun-li;FU Zhan-zhao;XU Hong-mei;ZHENG Lei.
Clinical observation on pleural perfusion of recombinant human endostain combined with cisplatin on malignant pleural effusion
[J]. CLINICAL FOCUS, 2013, 28(12): 1371-1373.
|
| [2] |
.
[J]. CLINICAL FOCUS, 2013, 28(11): 1278-1279.
|
| [3] |
.
[J]. CLINICAL FOCUS, 2013, 28(9): 1020-1021.
|
| [4] |
.
[J]. Clinical Focus, 2013, 28(2): 217-218.
|
| [5] |
.
[J]. Clinical Focus, 2012, 27(20): 1795-1796.
|
| [6] |
.
[J]. Clinical Focus, 2012, 27(7): 639-641.
|
| [7] |
.
[J]. Clinical Focus, 2011, 26(18): 1610-1611.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2011, 26(14): 1254-1255.
|
| [9] |
.
[J]. CLINICAL FOCUS, 2011, 26(7): 557-563.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2011, 26(1): 67-70.
|
| [11] |
HUANG Lu-ying;WU Yan-bing;JIANG Jing;LUO Ling.
Significance of soluble triggering receptor expressed on myeloid cells-1 in pleural effusions of various causes
[J]. CLINICAL FOCUS, 2010, 25(23): 2040-2042.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2010, 25(14): 1248-1250.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2010, 25(12): 1075-1078.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(11): 977-0.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2010, 25(9): 823-825.
|
